Sectors Life Sciences
Posted Jobs 0
Korro Bio is a privately held biotechnology company focused on the discovery and development of a new class of precision genetic medicines utilizing our propriety RNA editing platform, OPERA. Our portfolio of innovative RNA therapies has the potential to propel genetic medicine beyond rare genetic diseases into larger patient populations with common diseases. Korro enjoys support from a committed group of institutional investors, and recently completed a $116 million Series B financing round to advance our current and future work. We are located in Cambridge, Massachusetts.
Korro is committed to fostering a vibrant and supportive work environment that emphasizes diversity and inclusion, collaboration and shared success, and scientific rigor and innovation. At Korro, our positive culture and the respect shown to every employee are intertwined with our passion for advancing science to improve the lives of patients in our communities and beyond.